Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic importance of IDH mutations in chondrosarcoma: An individual patient data meta-analysis.

Cancer medicine - 1 Jul 2021

Vuong Huy Gia, Ngo Tam N M, Dunn Ian F

Abstract excerpt

INTRODUCTION: IDH1/2 mutations are prevalent in cartilaginous tumors including chondrosarcoma. This meta-analysis using individual patient data (IPD) aimed to investigate the clinical and prognostic association of these mutations in chondrosarcoma patients. METHODS: Two electronic databases including PubMed and Web of Science were searched for relevant data. We included studies providing IPD of chondrosarcoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Aged
Share to Bone Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Chondrosarcoma

Share to Isocitrate Dehydrogenase

Share to Prognosis

Share to Sex Factors

Share to Tumor Burden

Source

Open in PubMed Open full text

Identifiers

PMID: 34085407
DOI: 10.1002/cam4.4019
PMCID: PMC8267117

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic importance of IDH mutations in chondrosarcoma: An individual patient data meta-analysis.PMID 34085407Read ↗

Presence of IDH2 and TP53 mutations significantly reduces survival of patients with chondrosarcoma.Semantic proximity Read ↗

Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.Semantic proximity Read ↗

Prognostic impact of IDH mutations in chondrosarcoma.Semantic proximity Read ↗

Genomic Profiling Identifies Association of IDH1/IDH2 Mutation with Longer Relapse-Free and Metastasis-Free Survival in High-Grade ChondrosarcomaSemantic proximity Read ↗

Is the IDH Mutation a Good Target for Chondrosarcoma Treatment?Semantic proximity Read ↗

IDH1/2 Mutations Predict Shorter Survival in ChondrosarcomaSemantic proximity Read ↗

An Integrated Clinical Genomic and Transcriptomic Subgrouping of Central Chondrosarcoma.Semantic proximity Read ↗

IDH Mutations in Chondrosarcoma: Case Closed or Not?Semantic proximity Read ↗

IDH1 Mutation Induces HIF-1α and Confers Angiogenic Properties in Chondrosarcoma JJ012 Cells.Semantic proximity Read ↗

Genomic Characterization of Chondrosarcoma Reveals Potential Therapeutic TargetsSemantic proximity Read ↗

A genetic model for central chondrosarcoma evolution correlates with patient outcome.Semantic proximity Read ↗

Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.